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Inclusion body myopathy associated with
Paget's disease of bone and frontotemporal
dementia (IBMPFD)Valosin-containing protein (VCP or p97), a member of the AAA family (ATPases associated with diverse cellular
activities), plays a key role in many important cellular activities. A genetic deﬁciency of VCP can cause inclusion
bodymyopathy associatedwith Paget's disease of bone and frontotemporal dementia (IBMPFD). Previous studies
showed that the VCP N domain is essential for the regulation of nuclear entry of VCP. Herewe report that IBMPFD
mutations, which are mainly located in the N domain, suppress the nuclear entry of VCP. Moreover, the peptide
sequenceG780AGPSQ in the C-terminal region regulates the retention of VCP in the nucleus. Amutant lacking this
sequence can increase the nuclear distribution of IBMPFD VCP, suggesting that this sequence is a potential
molecular target for correcting the deﬁcient nucleocytoplasmic shuttling of IBMPFD VCP proteins.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Valosin-containing protein (VCP, or p97), a member of the ATPases
associated with diverse cellular activities (AAA) family, is one of the
most abundant proteins in cells [1]. It plays essential roles in many
cellular activities such as membrane fusion, protein degradation and
DNA repair [1–3]. The trafﬁc of VCP between the nucleus and cytoplasm
is a regulated process. Previous studies suggest that both the N domain
and the C-terminal regionmediate the nucleocytoplasmic shuttle of VCP
[4,5]. Structurally, VCP is comprised of an N domain, two conserved
ATPase domains D1 and D2, and a ﬂexible C-terminal region [1]. The
D1 domain is required for VCP to form a hexameric structure [6,7].AA,ATPasesassociatedwithdi-
denosine triphosphate; IBMPFD,
of bone and frontotemporal de-
P, ﬂuorescence recovery after
een the nucleus and cytoplasm;
n, Translational and Clinical
RB 1183H, 3500 N Broad St.,
+1 215 707 4743.The D2 domain provides the majority of the ATPase activity [8], and
the N domain binds various cofactors required for its diverse functions
[1,9]. In addition, the N domain is required for the nuclear entry of
VCP. Mutants bearing a deletion of the N domain are predominately
present in the cytoplasm, while wild type (WT) VCP is ubiquitously
distributed in the cells [4].
VCP mutations can cause inclusion body myopathy associated with
Paget's disease of bone and frontotemporal dementia (IBMPFD), an
inherited human multi-organ disorder [10,11]. All reported IBMPFD-
causing mutations are single amino acid substitutions and mostly
occur in the N-domain, suggesting a potential effect on the nucleo-
cytoplasmic shuttling of VCP.
Previous studies suggest that the N domain mediated nuclear entry
is regulated by the C-terminal region of VCP based on the study of its
homolog, Cdc48 in Saccharomyces cerevisiae. A stretch of acidic residues
(E828EDDDLY834S) in the C-terminal region can interact with the nuc-
lear localization signal sequence, RR28KKK, in the N domain to mask
its signaling [5]. Tyr834 phosphorylation leading to a conformational
change abolishes the attachment with RR28KKK to resume its nuclear
localization signaling [5]. However, VCP does not possess a typical
nuclear targeting signal sequence [5]. Even though the acidic peptide
is conserved in both VCP and Cdc48, the crystal structure of VCP does
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domain directly [12]. Thus, the mechanism of the nucleocytoplasmic
shuttling of VCP requires further investigation.
In this study, we analyzed the structural requirement for VCP to
shuttle between the nucleus and cytoplasm using a VCP–GFP chimeric
protein, and found that IBMPFD mutations (R95G, R155H or R155P,
R155C, R191Q and A232E) decrease the nuclear distribution of VCP
and the sequence G780AGPSQ in the C-terminal region regulates the
retention of VCP in the nucleus and nucleoli. In addition, the mutants
lacking this C-terminal sequence upregulate the nuclear retention of
IBMPFD mutants, suggesting that this C-terminal region may serve as
a molecular target for regulating the nucleocytoplasmic shuttling of
VCP.
2. Methods
2.1. DNA constructs
Mammalian VCP–GFP expression constructs, WT, VCP-Δ201–806,
VCP-Δ1–206, VCP-Δ780–806, VCP-Δ786–806, VCP-Δ797–806, A1, and
A2, were generated as previously reported [13]. In brief, mutations
were generated from pDNR-Dual-WT-VCP using the QuickChange™
Site-Directed Mutagenesis Kit (Stratagene). Then pLpEGFP-constructs
were produced through a recombination reaction to transfer the genes
in the pDNR-Dual-constructs to the pLpEGFP vector following the
manufacturer's protocol (Life Technologies Inc. Carlsbad, CA). IBMPFD
mutants of VCP were generated using the following oligonucleotides
and their corresponding complimentary strands (data not shown) in
the PCR cloning for individual mutants of pLpEGFP-VCP:
R95G, 5′-AGAGTTGTTCGGAATAACCTCCGAGTTGGCCTAGGAGATGTC
ATCAGCATC-3′;
R155C, 5′-CCGTAAAGGAGATATTTTTCTTGTCTGTGGTGGGATGCGT
GCTGTGGAG-3′;
R155H, 5′-CCGTAAAGGAGATATTTTTCTTGTCCATGGTGGGATGCGTG
CTGTGGAG-3′;
R155P, 5′-CCGTAAAGGAGATATTTTTCTTGTCCCGGGTGGGATGCGT
GCTGTGGAG-3′;
R191Q, 5′-CACTGTGAGGGGGAGCCAATCAAACAAGAGGATGAGGA
GGAATCCTTGAAT-3′;
A232E, 5′-ACTGAGACATCCTGCGCTCTTCAAGGAGATTGGTGTAAAG
CCTCCTCGGG-3′.
All introduced site-speciﬁc mutations and the deletion mutants
were conﬁrmed by DNA sequencing.
2.2. Cell culture and transfection
Human embryonic kidney (HEK) 293 cells and human osteosarcoma
(HOS) cells were grown in DMEM medium with 10% fetal calf serum
and 2 mM glutamine. Human primary neurons (ScienCell Research
Laboratories, Carlsbad, CA) were grown in neuronal medium with 10%
fetal calf serum, 1% of neuronal growth supplement and 2 mM gluta-
mine. All of these cells were cultured in an incubator with humidiﬁed
5% CO2 atmosphere. The cells were transfected with 2 μg or 0.2 μg
DNA constructs per well in 6-well or 96-well plates respectively using
lipofectamine 2000 (Life Technologies Inc.) following the
manufacturer's instructions and repeated for three times.
2.3. Immunoprecipitation and SDS-PAGE
HEK293 cells expressing VCP–GFP or GFP cultured in 6-well plates
were washed with ice-cold PBS, and then detached with 0.05% tryp-
sin/0.02% EDTA. After centrifugation at 500 ×g for 5 min, cell pellets
were lyzed in RIPA buffer supplemented with the protease inhibitorcocktail (Sigma-Aldrich, St. Louis, MO). Following centrifugation at
10,000 ×g for 30 min at 4 °C, 2 μg anti-GFP antibody (Sigma-Aldrich)
and 20 μL 50% Protein-G-Sepharose beads in lysis buffer were added
to 500 μL supernatants. The cell lysates were incubated for 2 h at 4 °C,
and then were transferred onto a 1 mL polypropylene column (Qiagen,
Valencia, CA). Afterwashingwith 10mLTBS, proteinswere eluted using
0.1 M pH 3.0 citrate acid/glycine buffer and immediately neutralized
with 1 M pH 9.0 Tris–HCl. The protein concentration was determined
using a BCAprotein assay kit (Thermo Scientiﬁc,Waltham,MA). Protein
samples were separated using 4–12% SDS-PAGE, transferred to nitro-
cellulose membranes, and then analyzed by immunoblotting with
anti-VCP and HRP-labeled secondary antibodies [13].2.4. Hexamerization assay using native gel electrophoresis
Protein complexes were resolved using Novex® NativePAGE™ Bis-
Tris gel system (Life Technologies Inc., Carlsbad, CA). Cell lysates were
mixed with native loading buffer, loaded to 3–16% native gel and run
electrophoresis for 1.5 h. The gel image of VCP–GFP was scanned
using FUJIFILM Fluoro-Image Analyzer FLA-5000 with excitation at
473 nm, CH1 at 400 V and resolution at 200 μm.2.5. ATPase assay
The ATPase activity of immunoprecipitated protein complexes was
analyzed by adding 10 μL protein complexes to ATPase assay buffer con-
taining 50 mM Tris–HCl (pH 8.0), 20 mM MgCl2, 1 mM EDTA, 1 mM
dithiothreitol (DTT), and 3 mM ATP for 15 min at 37 °C. The inorganic
phosphate released by ATP hydrolysis was measured as described [8].2.6. Cell cycle analysis
Cells wereﬁxed in 70% cold ethanol for 1 h,washed 3 timeswith PBS
containing 0.1% BSA, followed by treatment with RNase (1 U/mL) for
1 h, thenwere stained with 0.1% propidium iodide for 1 h, and analyzed
with ﬂow cytometry.2.7. Analysis of the ﬂuorescence intensity ratio between the nucleus and
cytoplasm (FIRNC)
Cells were cultured in 35 mm coverglass bottom dishes at 37 °C for
24 h. After transfection for 3 days, cells were imaged using a confocal
LSM510 Laser Scanning Microscope (Carl Zeiss, Germany) or Olympus
IX71 inverted ﬂuorescencemicroscopy equippedwith a DM1 CCD cam-
era. Theﬂuorescence intensity of VCP–GFP in thenucleus and cytoplasm
was measured using Image J 1.43u (http://rsb.info.nih.gov/ij) or
CellSens Dimension digital imaging analysis software 1.9 (Olympus
Inc.) and statistically analyzed using SPSS ver.16.0.2 software.2.8. Fluorescence recovery after photobleaching (FRAP) analysis
Cells were imaged with or without photobleaching using a confocal
LSM510 Laser Scanning Microscope (Carl Zeiss, Germany) equipped
with an Apochromat 40×/1.2 W objective and a 488 nm argon laser
line for illumination. Cell images were scanned with 488 nm excitation
at 2% intensity before or after bleaching. Photobleachingwas conducted
with a laser at 100% intensity and 100 iterations using 488 nm. The en-
tire regions of the nucleus or the cytoplasm were photobleached and
sequentially imaged at 1 min interval for 15 min. The ﬂuorescence re-
covery in the nucleus and cytoplasm was calculated using the Medical
Image Processing, Analysis and Visualization software (MIPAV) (Center
for Information Technology, National Institutes of Health).
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Nuclear and cytoplasmic fractions were prepared from the trans-
fected HEK293 cells using NE-PER Reagent (Thermo Fisher Scientiﬁc
Inc., Rockford, IL) following the manufacturer's instruction. The nuclear
and cytoplasmic fractions were mixed with loading buffer and resolved
using 4–12% SDS-PAGE (Life Technologies Inc.). The VCP–GFP variants
were detected using an anti-GFP antibody. Lamin A/C and GAPDH
were probed as the nuclear and cytoplasmic markers.
3. Results
3.1. VCP–GFP is functional in HEK293 cells
To study the nucleocytoplasmic shuttling of VCP,we employed VCP–
GFP as a reporter. Even though it has been used to indicate the cellular
localization of the VCP proteins previously [4,13,14], it is not clear that
this fusion protein retains the biological function of VCP. The human
embryonic kidney (HEK) 293 cell line was used as a cell model for its
high transfection efﬁciency and high level of protein expression. HereA
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with an anti-GFP antibody, and then immunoprecipitated protein com-
plexes were separated by SDS-PAGE, followed bywestern blotting with
an anti-VCP antibody. As shown in Fig. 1C (left panel), two VCP protein
bands corresponding to endogenous (97 kDa) and chimeric (124 kDa)
VCP were detected in cells transfected with VCP–GFP. Imaging analysis
indicates that the intensity of the VCP–GFP band is about 54.3% of VCP,
suggesting that VCP–GFP forms oligomers with endogenous VCP with
a ratio of 1 to 2. Furthermore, native gel electrophoresis showed a ﬂuo-
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functional characteristics of VCP in HEK293 cells.
3.2. The N domain deletant and IBMPFD mutants of VCP manifest lower
nuclear distribution than WT VCP
The N domain plays an important role for VCP to transport into the
nucleus, and its deletion suppresses the nuclear entry of VCP (Fig. 2A)
[4]. Quantitative image analysis of the N-terminal 1–206 deletion
(VCP-Δ1–206) was carried out by measuring the ﬂuorescence intensity
ratio between the nucleus and cytoplasm (FIRNC), and the results
showed that the nuclear distribution of VCP-Δ1–206 was 70% lower
than theWTVCP–GFP (Fig. 2B). Since IBMPFDmutations predominately
locate in the N domain or at the interface between N domain and D1
domain [10,11], we hypothesize that these mutants also affect theC
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Fig. 2. IBMPFD mutations decrease the nuclear distribution of VCP. HEK293 cells were transien
microscopy (A) and then images were quantitatively analyzed using image J software. The st
28) (B). (C) IBMPFD mutants were transfected to HEK293 cells, HOS cells and primary neuron
of the ﬂuorescence intensity ratio between the nucleus and the cytoplasm (FIRNC) in HEK293
ware. The result shows that the FIRNC of all the IBMPFD mutants is signiﬁcantly lower than Wnucleocytoplasmic shuttling of VCP. We generated 6 representative
IBMPFD mutants (R95G, R155C, R155H, R155P, R191Q and A232E)
using site-speciﬁc mutagenesis, and then expressed them in HEK293
cells, HOS cells and primary neurons followed by cell imaging. Indeed,
these mutants showed lower ﬂuorescence intensity in the nucleus
when compared to WT VCP in all of these three cell lines (Fig. 2C).
Since bone and nervous tissues manifest major pathological change in
IBMPFD patients [10], the distributions of VCPWT and IBMPFDmutants
in osteoblasts andneurons are similar as inHEK293 cellswhich suggests
that the deﬁciency in the nuclear distribution of IBMPFD mutants may
be relevant to the disease and HEK293 could serve as a cell model for
the VCP nucleocytoplasmic shuttling study. Image analysis showed
that the FIRNCs of all of these IBMPFD mutants were signiﬁcantly
lower than the WT VCP–GFP in HEK293 cells (p b 0.001, n = 50).
Among these transfectants, R155C and R155H exhibit approximatelyB
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226 C. Song et al. / Biochimica et Biophysica Acta 1853 (2015) 222–23260% of the FIRNC of WT VCP, which was also less than R191Q (p b 0.05,
n = 50) (Fig. 2D). This result suggests that these IBMPFD mutations
suppress nucleocytoplasmic shuttling of VCP, and R155C and R155H
have the most signiﬁcant effect on nuclear entry.
3.3. Characterization of the nucleocytoplasmic shuttling of VCP
The nucleocytoplasmic shuttling of VCP was further examined
by measuring the recovery of the ﬂuorescence of VCP–GFP after
photobleaching. Following the photobleach of the nucleus, the recov-
ered ﬂuorescence showed a noticeable increase within cells expressing
GFP in 4 s, which was then elevated over time (Fig. 3A). The ﬂuores-
cence recovery of VCP–GFPwasmuch slower thanGFP alone. The recov-
ered ﬂuorescence intensity of VCP–GFP in the nucleus was only 5%, as
compared to 50% for GFP alone in 60 s (Fig. 3B). GFP reached an equilib-
rium state between the cytoplasm and nucleus at 6 min while the
nuclear concentration of VCP–GFP only recovered approximately 20%.
It suggests that VCP–GFP possesses a mechanism for nuclear entry,
which is distinct from GFP.
3.4. Effect of ATPase activity on the nucleocytoplasmic shuttling of VCP
The IBMPFD mutations have varied effect on the ATPase activity of
VCP. While most of these mutants show slightly elevated ATPase
activity, R155C and A232Emutants exhibit approximately a two fold in-
crease [16–18], suggesting that the altered nucleocytoplasmic shuttling
of these mutants may not have been due to the altered ATPase activity.
We analyzed the cellular distribution of the site-speciﬁc mutant of VCP
lacking ATP binding or ATP hydrolysis, A1 or A2, and calculated the
FIRNC from the confocal microscopy obtained images and found that
both A1 and A2 were present at lower levels in the nucleus than in
the cytoplasm (Fig. 4A). The FIRNC of these two mutants was about
50% of WT VCP (Fig. 4B). This suggests that the ATPase activity affects
the nucleocytoplasmic shuttling of VCP. However, the suppressed
nucleocytoplasmic shuttling of N domainmutants is not caused directly
through their effect on ATPase activity.
3.5. The C-terminal region regulates the nuclear export of VCP
Since the C-terminal region of the yeast homolog of VCP, Cdc48,
regulates nuclear entry, we examined the role of the C-terminal region
of VCP on nucleocytoplasmic shuttling. We generated three sequential
C-terminal deletion mutants using WT VCP–GFP as a template. Both
VCP-Δ780–806 and VCP-Δ786–806 lack the acidic sequence,
E798DNDDDLY, in the C-terminal region, but both of them showedA
Pre 0 sec 4 sec 60 sec
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GFP
WT
Fig. 3. FRAP analysis of the nuclear entry of VCP–GFP in HEK293 cells. (A) The nucleus of the cell
the ﬂuorescence images were obtained at 4 s intervals over 400 s by confocal microscopy. (B) Q
single exponential FRAP of MIPAV software, where differences in ﬂuorescence recovery rate wsimilar distribution patterns asWT VCP–GFP (Figs. 5A and 2A), suggest-
ing that this acidic sequence was not involved in regulating the nuclear
entry of VCP. Surprisingly, the VCP-Δ780–806 mutant predominately
accumulated in the nucleus as indicated by the colocalization of the
high intensity green ﬂuorescence of VCP-Δ780–806 within the Hoechst
33342 stained nucleus (Fig. 5A and C). FIRNC analysis showed that the
nuclear concentration of VCP-Δ780–806 is about 2-fold higher than
that of the cytoplasm, and the FIRNC of VCP-Δ780–806 is signiﬁcantly
higher than that of VCP-Δ786–806 and VCP-Δ797–806 (Fig. 5B).
In addition, the results show that VCP-Δ780–806 proteins form foci
in the nucleus (Fig. 5A, indicated by red arrows). We hypothesize that
these foci reside at the nucleoli, sites for ribosome assembly, because
VCP can bind misfolded proteins [19] and the nucleoli function as the
deposition sites for misfolded proteins, heat shock proteins and
proteasomes [20–22]. We ﬁxed these cells with cold methanol and
stained cells with an antibody to detect the nucleolin proteins, the
marker of nucleoli. Cell imaging showed that the VCP-Δ780–806 and
VCP-Δ786–806 proteins were leaked out the nucleus after ﬁxation,
but VCP-Δ780–806 proteins were retained in foci and colocalized with
the nucleoli (Fig. 5D).
To further determine the effect of the deletion of the G780AGPSQ
sequence on the nuclear entry of VCP, we performed FRAP analysis to
determine the shuttle efﬁciency of VCP-Δ780–806 in crossing thenucle-
ar membrane. The results showed that the ﬂuorescence recovery of
VCP-Δ780–806 in the nucleus was more rapid than in the cytoplasm,
while WT VCP showed similar recovery efﬁciency in both the nucleus
and the cytoplasm (Fig. 6A). In addition, the recovery of VCP-Δ780–
806 in the nucleus is approximately twice as fast as that of WT
(Fig. 6B). Thus, the G780AGPSQ sequence plays a critical role in regulat-
ing the export of VCP from the nucleus and nucleoli to the cytoplasm,
and may serve as a nuclear export signal.3.6. VCP-Δ780–806 increases the nuclear distribution of N domainmutants
To increase the nuclear distribution of IBMPFD mutants of VCP, we
hypothesize that overexpression of WT VCP cannot overcome this deﬁ-
ciency, but theG780AGPSQdeletant could promote thenuclear retention
of the N domain mutants. The reason is that VCP–GFP proteins are
hexamerized with endogenous VCP proteins in cells (Fig. 1). The deﬁ-
ciency in the nuclear distribution manifested by these hybrid hexamers
suggests that the intact hexameric N domains are required for the
nuclear entry of VCP. Therefore, overexpression of WT VCP cannot
enable these IBMPFD mutants to form intact hexameric N domains for
mediating their nuclear entry. However, since VCP-Δ780–806 has a
higher nuclear retention capability than WT VCP, it may elevate theB
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We transfected VCP-Δ780–806 or WT with IBMPFD mutants or VCP-
Δ1–206 in HEK293 cells, and as expected, the ﬂuorescence intensity of
R155H and VCP-Δ780–806 co-transfected in the nucleus was clearly
higher than R155H and WT co-expressing cells (Fig. 7A). Further cell
imaging analysis showed that the FIRNC of the WT and IBMPFD co-
transfectant did not show signiﬁcant increases. On the other hand, the
FIRNC of VCP-Δ780–806 and R155H was elevated approximately 2-
fold (Fig. 7B). Moreover, western blotting analysis showed that the pro-
tein amount of R155H was lower in the nuclear fraction than theC
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Fig. 5. The sequence 780–785 in the C-terminal region regulates VCP–GFP retention in the nucle
mutant VCP-Δ780–806, VCP-Δ786–806 and VCP-Δ797–806 for 16 h. The imageswere taken un
not VCP-Δ786–806 and VCP-Δ797–806, accumulates in the nucleus and forms foci as indicated
as theﬂuorescence intensity ratio between thenucleus and the cytoplasmcalculated usingMIPA
Hoechst 33342 and imagedwith ﬂuorescencemicroscope and the images of the green ﬂuoresce
expressing VCP-Δ780–806 andVCP-Δ786–806mutantswereﬁxedwith coldmethanol and stain
using confocal microscopy (scale bar = 5 μM).cytoplasmic fraction (Fig. 7C, lane 1 vs 2). The expression of VCP-
Δ780–806, but not VCP-Δ1–206 or WT, with R155H led to an increase
of R155H in the nuclear fraction (Fig. 7C, lanes 5 vs 6, 3 vs 4 and 7 vs
8). These data suggest that VCP-Δ780–806 elevated the nuclear distri-
bution of the R155H mutant.
We further examined the effect of VCP-Δ780–806 on the nuclear
distribution of other IBMPFD mutants in HEK293 cells, and found that
VCP-Δ780–806 had similar effects for all of them. The FIRNCs of cells
co-expressing VCP-Δ780–806 with R95G, R155C, R155P, Q191A or
A232E are 1.29 ± 0.42, 1.18 ± 0.39, 1.13 ± 0.22, 1.15 ± 0.26 andg h
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Δ780–806 can promote the nuclear distribution of IBMPFD mutants.
Since the C-terminal region may affect the N domain mutants on
other subunits or the same subunit in the hexamer, we examined the
in trans and in cis effects using cells expressing both of the VCP-Δ780–
806 and VCP-Δ1–206 proteins or VCP-Δ1–206–Δ780–806 proteins
(Fig. 8). The nuclear ﬂuorescence intensity was increased around 2.1-
fold in the cells with co-transfection of VCP-Δ780–806 and VCP-Δ1–
206 compared toVCP-Δ1–206 only (Fig. 8A andB). Thewestern blotting
analysis showed that the protein amount of VCP-Δ780–806 was higher
in the nuclear fraction than the cytoplasmic fraction while VCP-Δ1–206
was predominately in the cytoplasmic fraction (Fig. 8C, lanes 1 vs 2 and
5 vs 6). The expression of VCP-Δ780–806 caused the increase of VCP-
Δ1–206 in the nucleus (Fig. 8C, lanes 3 vs 4 and 5 vs 6). These results
suggest that the C-terminal region can increase the retention of the N
domain deletion in trans. In addition, the nuclear ﬂuorescence of VCP-
Δ1–206–Δ780–806 was also higher than VCP-Δ1–206. The FIRNC of
these cells was increased by approximately 1.5-fold (Fig. 8A and B).
The western blotting analysis showed that the protein amount of VCP-
Δ1–206–Δ780–806 in the nuclear fraction is slightly higher than VCP-
Δ1–206 (Fig. 8C, lanes 7 vs 8 and 5 vs 6), suggesting that the C-
terminal region can also increase the nuclear distribution in cis, but
with lower efﬁciency than the effect in trans. Thus, theC-terminal region
of VCP can regulate the nuclear entry of VCP both in trans and in cis.4. Discussion
In the past 20 years, studies have established that VCP plays critical
roles in a number of cellular activities. VCP not only maintains
proteostasis through mediating protein degradation via the ubiquitin
proteasome system, autophagy and collecting protein aggregates to
aggresomes, but is also involved in nuclear formation and maintenance
of DNA integration [1–3]. Nucleocytoplasmic shuttling is essential for
VCP to function spatially in the nucleus and cytoplasm. Previous studies
have suggested that theN domain is involved in the regulation of nucle-
ar entry based onN domain deletion of VCP. However, whether the site-
speciﬁcmutation of VCP affects the nuclear distribution is unclear. In ad-
dition, whether the C-terminal region of VCP retains similar regulatory
function as its homolog Cdc48 remains unknown. As summarized in
Fig. 9, here we show that the IBMPFD mutants in the N domain, or N–
D1 domain interface, suppress the nuclear entry of VCP. In contrast,
the C-terminal region deletion causes VCP to accumulate in the nucleus.
In addition, the C-terminal deletion can promote the nuclear concentra-
tion of N domain mutants. These ﬁndings further clarify the role of N
domain in regulating nuclear entry and reveal that the G780AGPSQ se-
quence in the C-terminus regulates the nuclear export of VCP which
may serve as a nuclear export signal.
In our studies, we utilize the VCP–GFP fusion protein to assess the
kinetic distribution of VCP. It has previously been used to analyze the
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that VCP–GFP demonstrated similar function as WT VCP in the forma-
tion of aggresomes [13]. However, the biological characterization of
the fusion protein has not been evaluated. Here, we determined the
key biological features of VCP–GFP including the distribution pattern,
oligomerization properties and ATPase activity, and found that all of
these features of VCP–GFP are similar to WT VCP. This indicates that
the fusion of GFP does not affect the biological function of VCP.
Previous studies showed that theNdomain is essential for the nucle-
ar entry of VCP [4], and the deletion of the N domain suppresses the
nuclear entry. The IBMPFDmutations are scatteredwithin theNdomain
or N–D1 interface (A232E) [10], but whether these mutations affect
nucleocytoplasmic shuttling of VCP was unknown. By imaging analysis
of the transfected HEK293 cells, we found that all of these mutants ex-
hibit decreased nuclear distribution compared with WT VCP. Since
these mutations are widely distributed in the N domain, the traditional
NLS cannot explain why they all affect the nuclear distribution of VCP.
Since these mutations alter the conformation of the N domain [23],
this may suggest that VCP interacts with a docking protein on the
nuclear membrane via the N domain. The defective N domain of these
mutants may suppress the binding of VCP to the docking proteins
required for nuclear entry.
In addition, we found that the C-terminal region of VCP exhibits a
different regulatory mechanism when compared with Cdc48. Although
the amino acid sequence E799NDDDLY in VCP is homologous to the reg-
ulatory sequence E828EDDDLY in Cdc48, it is not required for regulatingthe nucleocytoplasmic shuttling of VCP because C-terminal deletion
mutants of VCP (e.g. VCP-Δ786–806 and VCP-Δ797–806) lacking this
sequence still show similar nuclear distribution as WT VCP. Instead,
the sequence, G780AGPSQ, in the C-terminal region, regulates the nucle-
ar export of VCP. The deletion of this sequence in VCP-Δ780–806, but
not VCP-Δ786–806 and VCP-Δ797–806, causes high accumulation of
VCP in the nucleus. A blast search of the Cdc48 sequence (GenBank:
CAA98694.1, http://blast.ncbi.nlm.nih.gov) does not reveal any homo-
log of G780AGPSQ. Thus, although Cdc48 and VCP are evolutionally con-
served in protein degradation, they still use different mechanisms to
regulate their nuclear retention.
Interestingly, a homolog of VCP, nuclear valosin-containing protein-
like isoform 2 (NVL2), is mainly distributed in the nucleus and nucleoli
[24]. Blast analysis of human VCP (accession P55072) and NVL2 (acces-
sion NP_002524) shows that these two proteins have no similarity in
the N domain, the other regions share 59% homology but the
G780AGPSQ sequence is absent in NVL2. This implies that lacking this
nuclear export sequence could contribute to the accumulation of NVL2
in the nucleus and nucleoli.
It remains unclear whether the nuclear export signal (NES) of VCP
interacts with export receptors. CRM1 (chromosome region main-
tenance 1 or exportin1) is a member of the importin β superfamily of
nuclear transport receptors, and recognizes proteins bearing a leucine-
rich nuclear export sequence [25,26]. This sequence is present in a
number of proteins, such as human T-cell leukemia type I Rex [27],
cAMP-dependent protein kinase inhibitor [28], and mitogen-activated
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without any leucine residues, suggesting that it may function through
different nuclear transport receptors.
Even though the ATPase activity of VCP plays an important role in
various cellular functions, we found that it is not sufﬁcient for the
nucleocytoplasmic shuttling of VCP. The N domain deletion mutant ex-
hibits normal ATPase activity of VCP [30], while it lacks the capacity for
nuclear entry [4,14]. Similarly, the IBMPFD mutants exhibit increased
ATPase activity [16–18], yet all of them also showed decreased nuclear
distribution. However, mutation of either the D1 or D2 domain leads
to a decrease of nuclear distribution. This seemingly contradictory ob-
servation suggests that although IBMPFD mutants affect both the inter-
action of VCPwith other proteins and the ATPase activity, the enhanced
ATPase activity of these mutants is likely due to less of an impact by a
potential N domain conformational change [23]. Previous studies
showed that restraining the conformational change of the N domain
by binding to cofactors such as p47 suppresses the ATPase activity of
VCP [30,31]. This suggests that the binding of the N domain to docking
proteins is a primary gateway for VCP to enter the nucleus, while the
ATPase activity may be required to regulate the N domain conforma-
tional change during the nuclear entry process.
Although mutation can induce protein misfolding, protein aggrega-
tion is not a cause of the abnormal localization of the IBMPFD mutants.
Because VCP is amolecular chaperone, even thedeletionmutants of VCP
still can prevent protein aggregation [19]. The recombinant proteins of
IBMPFDmutants such as R155C and A232E showed similar elution pro-
ﬁles as WT VCP in the gel ﬁltration analysis [16]. It suggests that these
mutations do not cause VCP aggregation. In addition, these IBMPFDmu-
tants manifest normal or elevated ATPase activity [16–18], suggesting
that the altered structures of IBMPFD mutants remain enzymatically
functional. In our experiments, we observed that these IBMPFDproteins
are mainly in the soluble fractions (Fig. 7C and data not shown). Thus,
the dysregulated nucleocytoplasmic shuttling of IBMPFD mutants is
not caused by protein aggregation.
Finally, we showed that the C-terminal region can promote the
nuclear entry of N domain mutants. Co-transfection of VCP-Δ780–806
increases the nuclear distribution of VCP-Δ1–206 and IBMPFDmutants.
Since hexamerization is mainly achieved through the D1 domain and
GFP does not affect the hexamerization of VCP, VCP-Δ780–806 should
form hybrids with the N domain mutants. In this way, VCP-Δ780806
promotes the nuclear entry of N domain deletion and IBMPFD mutants
in trans. Consistently, co-transfection of WT-GFP does not signiﬁcantly
increase the nuclear distribution of VCP, suggesting that most of WT-
GFP proteins hybridize with N domain mutants and exhibit suppressed
nuclear entry. In addition, VCP-Δ1–206–Δ780–806 with the double de-
letion of both the N domain and the C-terminal region showed higher
nuclear distribution than VCP-Δ1–206, suggesting that G780AGPSQ
also increases the nuclear distribution in cis. Thus the C-terminal region
may be a potential molecular target for screening chemical entities to
increase the nuclear distribution of IBMPFD VCP proteins.
Acknowledgements
We thankDrs. Carlos Barrero, YingWang and Ren-MingDai for tech-
nical support, and Dr. Madesh Muniswamy for providing the confocal
imaging facility. The content of this publication does not necessarily
reﬂect the views or policies of the Department of Health and Human
Services nor does mention of trade names, commercial products, or
organizations imply endorsement by theUSGovernment. The publisher
or recipient acknowledges the right of the US Government to retain a
nonexclusive, royalty-free license in and to any copyright covering the
manuscript. This research was funded by NIEHS 1R21ES023051 for
C.S. Other supports include: DA-14230, DA-25532, and DA-13429 for
T.J.R.; NCI Contract Nos. NO1CO56000 and HHSN261200800001E for
S.L.; Intramural Research Program of the NIH National Cancer Institute
Center for Cancer Research under contract N01-CO-12400 for N.C.,C.C.L. and J.M.W.; National Natural Science Foundation of China Nos.
30672433 and 30271215 and Natural Science Foundation of Shandong
Province No. 1872010ZRE27212 for S.C.Z.
References
[1] Q. Wang, C. Song, C.C. Li, Molecular perspectives on p97–VCP: progress in under-
standing its structure and diverse biological functions, J. Struct. Biol. 146 (2004)
44–57.
[2] H. Meyer, M. Bug, S. Bremer, Emerging functions of the VCP/p97 AAA-ATPase in the
ubiquitin system, Nat. Cell Biol. 14 (2012) 117–123.
[3] K. Yamanaka, Y. Sasagawa, T. Ogura, Recent advances in p97/VCP/Cdc48 cellular
functions, Biochim. Biophys. Acta 1823 (2012) 130–137.
[4] J.J. Partridge, J.O. Lopreiato Jr., M. Latterich, F.E. Indig, DNA damagemodulates nucle-
olar interaction of theWerner protein with the AAA ATPase p97/VCP, Mol. Biol. Cell
14 (2003) 4221–4229.
[5] F. Madeo, J. Schlauer, H. Zischka, D. Mecke, K.U. Frohlich, Tyrosine phosphorylation
regulates cell cycle-dependent nuclear localization of Cdc48p, Mol. Biol. Cell 9
(1998) 131–141.
[6] Q. Wang, C. Song, X. Yang, C.C. Li, D1 ring is stable and nucleotide-independent,
whereas D2 ring undergoes major conformational changes during the ATPase
cycle of p97–VCP, J. Biol. Chem. 278 (2003) 32784–32793.
[7] X. Zhang, A. Shaw, P.A. Bates, R.H. Newman, B. Gowen, E. Orlova, M.A. Gorman, H.
Kondo, P. Dokurno, J. Lally, G. Leonard, H. Meyer, M. van Heel, P.S. Freemont, Struc-
ture of the AAA ATPase p97, Mol. Cell 6 (2000) 1473–1484.
[8] C. Song, Q. Wang, C.C. Li, ATPase activity of p97–valosin-containing protein (VCP).
D2 mediates the major enzyme activity, and D1 contributes to the heat-induced ac-
tivity, J. Biol. Chem. 278 (2003) 3648–3655.
[9] H.O. Yeung, P. Kloppsteck, H. Niwa, R.L. Isaacson, S. Matthews, X. Zhang, P.S.
Freemont, Insights into adaptor binding to the AAA protein p97, Biochem. Soc.
Trans. 36 (2008) 62–67.
[10] G.D. Watts, J. Wymer, M.J. Kovach, S.G. Mehta, S. Mumm, D. Darvish, A. Pestronk,
M.P. Whyte, V.E. Kimonis, Inclusion body myopathy associated with Paget disease
of bone and frontotemporal dementia is caused by mutant valosin-containing pro-
tein, Nat. Genet. 36 (2004) 377–381.
[11] M. Badadani, A. Nalbandian, G.D. Watts, J. Vesa, M. Kitazawa, H. Su, J. Tanaja, E.
Dec, D.C. Wallace, J. Mukherjee, V. Caiozzo, M. Warman, V.E. Kimonis, VCP asso-
ciated inclusion body myopathy and paget disease of bone knock-in mouse
model exhibits tissue pathology typical of human disease, PLoS ONE 5 (2010)
e13183.
[12] B. DeLaBarre, A.T. Brunger, Complete structure of p97/valosin-containing protein re-
veals communication between nucleotide domains, Nat. Struct. Biol. 10 (2003)
856–863.
[13] C. Song, Z. Xiao, K. Nagashima, C.C. Li, S.J. Lockett, R.M. Dai, E.H. Cho, T.P. Conrads,
T.D. Veenstra, N.H. Colburn, Q.Wang, J.M.Wang, The heavy metal cadmium induces
valosin-containing protein (VCP)-mediated aggresome formation, Toxicol. Appl.
Pharmacol. 228 (2008) 351–363.
[14] F.E. Indig, J.J. Partridge, C. Kobbe Cv, M.I. Aladjem, M. Latterich, V.A. Bohr, Werner
syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent
fashion, J. Struct. Biol. 146 (2004) 251–259.
[15] Q.Wang, C. Song, C.C. Li, Hexamerization of p97–VCP is promoted by ATP binding to
the D1 domain and required for ATPase and biological activities, Biochem. Biophys.
Res. Commun. 300 (2003) 253–260.
[16] H. Niwa, C.A. Ewens, C. Tsang, H.O. Yeung, X. Zhang, P.S. Freemont, The role of the N-
domain in the ATPase activity of themammalian AAA ATPase p97/VCP, J. Biol. Chem.
287 (2012) 8561–8570.
[17] D. Halawani, A.C. LeBlanc, I. Rouiller, S.W. Michnick, M.J. Servant, M. Latterich, He-
reditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain
and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation,
Mol. Cell. Biol. 29 (2009) 4484–4494.
[18] A.Manno,M. Noguchi, J. Fukushi, Y. Motohashi, A. Kakizuka, Enhanced ATPase activ-
ities as a primary defect of mutant valosin-containing proteins that cause inclusion
body myopathy associated with Paget disease of bone and frontotemporal demen-
tia, Genes Cells 15 (2010) 911–922.
[19] C. Song, Q. Wang, C.C. Li, Characterization of the aggregation-prevention activity of
p97/valosin-containing protein, Biochemistry 46 (2007) 14889–14898.
[20] J.R. Subjeck, T. Shyy, J. Shen, R.J. Johnson, Association between the mammalian
110,000-dalton heat-shock protein and nucleoli, J. Cell Biol. 97 (1983)
1389–1395.
[21] L. Latonen, H.M. Moore, B. Bai, S. Jaamaa, M. Laiho, Proteasome inhibitors induce nu-
cleolar aggregation of proteasome target proteins and polyadenylated RNA by alter-
ing ubiquitin availability, Oncogene 30 (2011) 790–805.
[22] A. Palanca, I. Casafont, M.T. Berciano, M. Lafarga, Reactive nucleolar and Cajal body
responses to proteasome inhibition in sensory ganglion neurons, Biochim. Biophys.
Acta 1842 (2014) 848–859.
[23] W.K. Tang, D. Li, C.C. Li, L. Esser, R. Dai, L. Guo, D. Xia, A novel ATP-dependent con-
formation in p97 N-D1 fragment revealed by crystal structures of disease-related
mutants, EMBO J. 29 (2010) 2217–2229.
[24] Y. Fujiwara, K. Fujiwara, N. Goda, N. Iwaya, T. Tenno, M. Shirakawa, H. Hiroaki, Struc-
ture and function of the N-terminal nucleolin binding domain of nuclear valosin-
containing protein-like 2 (NVL2) harboring a nucleolar localization signal, J. Biol.
Chem. 286 (2011) 21732–21741.
[25] S. Hutten, R.H. Kehlenbach, CRM1-mediated nuclear export: to the pore and beyond,
Trends Cell Biol. 17 (2007) 193–201.
232 C. Song et al. / Biochimica et Biophysica Acta 1853 (2015) 222–232[26] B. Ossareh-Nazari, F. Bachelerie, C. Dargemont, Evidence for a role of CRM1 in signal-
mediated nuclear protein export, Science 278 (1997) 141–144.
[27] D. Palmeri, M.H. Malim, The human T-cell leukemia virus type 1 posttranscrip-
tional trans-activator Rex contains a nuclear export signal, J. Virol. 70 (1996)
6442–6445.
[28] W. Wen, J.L. Meinkoth, R.Y. Tsien, S.S. Taylor, Identiﬁcation of a signal for rapid ex-
port of proteins from the nucleus, Cell 82 (1995) 463–473.
[29] M. Fukuda, I. Gotoh, Y. Gotoh, E. Nishida, Cytoplasmic localization of mitogen-
activated protein kinase kinase directed by its NH2-terminal, leucine-rich shortamino acid sequence, which acts as a nuclear export signal, J. Biol. Chem. 271
(1996) 20024–20028.
[30] Q.Wang, C. Song, L. Irizarry, R. Dai, X. Zhang, C.C. Li, Multifunctional roles of the con-
served Arg residues in the second region of homology of p97/valosin-containing
protein, J. Biol. Chem. 280 (2005) 40515–40523.
[31] H.H. Meyer, H. Kondo, G. Warren, The p47 co-factor regulates the ATPase activity of
the membrane fusion protein, p97, FEBS Lett. 437 (1998) 255–257.
